ValuEngine lowered shares of Rewalk Robotics (NASDAQ:RWLK) from a hold rating to a sell rating in a research report released on Friday.
A number of other equities research analysts have also recently commented on RWLK. Oppenheimer set a $2.00 price target on shares of Rewalk Robotics and gave the stock a buy rating in a report on Friday, August 24th. Zacks Investment Research upgraded shares of Rewalk Robotics from a hold rating to a buy rating and set a $1.25 price target for the company in a report on Thursday, August 30th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. Rewalk Robotics presently has an average rating of Hold and a consensus price target of $1.85.
Shares of RWLK remained flat at $$0.20 during trading hours on Friday. 3,704,898 shares of the stock traded hands, compared to its average volume of 1,845,086. Rewalk Robotics has a 52 week low of $0.19 and a 52 week high of $1.35. The firm has a market capitalization of $7.32 million, a PE ratio of -0.20 and a beta of 0.60.
Rewalk Robotics (NASDAQ:RWLK) last posted its quarterly earnings data on Thursday, November 8th. The medical device company reported ($0.13) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. Rewalk Robotics had a negative net margin of 352.11% and a negative return on equity of 3,654.32%. The company had revenue of $1.62 million during the quarter, compared to analysts’ expectations of $2.12 million. On average, equities research analysts expect that Rewalk Robotics will post -0.67 EPS for the current fiscal year.
About Rewalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Featured Story: How Do Tariffs Affect Trade Balances?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.